Found 34 matching trials
COVID Protection After Transplant-Immunosuppression Reduction PHASE2 This study will enroll individuals who have:
* Completed primary series of...
Show More Location
University of California, San Diego
Learn More & Join Trial
A Study of Ruxolitinib for Preventing Graft-Versus-Host Disease in People With a Hematologic Malignancy Who Will Receive a Stem Cell Transplant PHASE2 The researchers are doing this study to compare 2 different GVHD prevention...
Show More Location
Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities)
Learn More & Join Trial
Allogeneic Regulatory Dendritic Cell (DCreg) Renal Study PHASE1 This study will evaluate the safety and feasibility of treatment involving ...
Show More Status
Active Not Recruiting
Location
University of Pittsburgh, Starzl Transplantation Institute
Learn More & Join Trial
Extended-Release Tacrolimus Following Liver Transplantation PHASE4 Medications used after transplant to prevent rejection are associated with ...
Show More Location
Univerity of Alberta
Learn More & Join Trial
Sirolimus, Tacrolimus, and Antithymocyte Globulin in Preventing Graft-Versus-Host Disease in Patients With Hematologic Cancer Who Are Undergoing Donor Stem Cell Transplant PHASE2 RATIONALE: Giving low doses of chemotherapy, monoclonal antibodies, and rad...
Show More Location
Barbara Ann Karmanos Cancer Institute
Learn More & Join Trial
Assessment of Biomarker-Guided CNI Substitution In Kidney Transplantation PHASE2 800 adult first time kidney transplant recipients will be enrolled in the O...
Show More Location
University of Alabama School of Medicine: Transplantation
Learn More & Join Trial
A Dose Escalation Study of TCD601 Compared to ATG in de Novo Renal Transplantation PHASE2 The purpose of this study is to investigate the safety, tolerability, pharm...
Show More Location
Innsbruck Medical University
Learn More & Join Trial
Randomized Conversion of Calcineurin-Inhibitors in Renal Allograft Recipients PHASE4 This study is being done to investigate the impact of changing immunosuppre...
Show More Location
Northwestern Memorial Hospital
Learn More & Join Trial
Phase II Study Evaluating the Efficacy of Tacrolimus Extended Release Tablets to Twice Daily Tacrolimus Dosing Regimen PHASE2 This phase II, single-center, open-label study will evaluate the comparable...
Show More Location
Baylor University Medical Center
Learn More & Join Trial
CAMPath and BELimumab for Transplant Tolerance in Sensitized Kidney Transplant Recipients PHASE2 The purpose of this research study is to determine whether kidney transplan...
Show More Location
University of Wisconsin Hospitals and Clinics
Learn More & Join Trial